Semaglutide injections are helping you lose weight-but if yours isn't FDA-approved (and a lot of them aren't), it could be ...

In a Cleveland Clinic cohort, patients who stopped treatment for obesity had smaller weight losses to start, making these ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...

All eyes were on GLP-1 therapies in 2024, and there’s certainly no signs of a slowdown. One in eight US adults say they’ve taken a GLP-1. The global market is projected to reach $100 billion ...

The largest observational study of GLP-1 weight-loss drugs suggests their benefits could be wide-ranging, but there are some risks to consider.

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

Discover how GLP-1 drugs are driving demand for new supplements. Insights from Vitafoods Europe 2025 reveal how the industry ...

First, the stock has sliced through two support levels. Shares broke through their 50-day moving average on Monday for the ...

WITH Mounjaro users shedding nearly double the amount of weight compared to its other counterparts, it’s no wonder the ...

Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...